nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.363	1	CbGaD
Diphenhydramine—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.0991	0.203	CbGbCtD
Diphenhydramine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.065	0.133	CbGbCtD
Diphenhydramine—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0547	0.112	CbGbCtD
Diphenhydramine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.035	0.0716	CbGbCtD
Diphenhydramine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.035	0.0716	CbGbCtD
Diphenhydramine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0291	0.0596	CbGbCtD
Diphenhydramine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0291	0.0596	CbGbCtD
Diphenhydramine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0274	0.0562	CbGbCtD
Diphenhydramine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0266	0.0545	CbGbCtD
Diphenhydramine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0266	0.0545	CbGbCtD
Diphenhydramine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0237	0.0485	CbGbCtD
Diphenhydramine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.022	0.0451	CbGbCtD
Diphenhydramine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0147	0.0301	CbGbCtD
Diphenhydramine—Epigastric distress—Salbutamol—chronic obstructive pulmonary disease	0.00281	0.0288	CcSEcCtD
Diphenhydramine—Extrasystoles—Aminophylline—chronic obstructive pulmonary disease	0.0018	0.0185	CcSEcCtD
Diphenhydramine—Extrasystoles—Formoterol—chronic obstructive pulmonary disease	0.00137	0.0141	CcSEcCtD
Diphenhydramine—Extrasystoles—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.0141	CcSEcCtD
Diphenhydramine—Extrasystoles—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.0133	CcSEcCtD
Diphenhydramine—Chest discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.0126	CcSEcCtD
Diphenhydramine—Wheezing—Montelukast—chronic obstructive pulmonary disease	0.0011	0.0113	CcSEcCtD
Diphenhydramine—Wheezing—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.0109	CcSEcCtD
Diphenhydramine—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.0108	CcSEcCtD
Diphenhydramine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.0107	CcSEcCtD
Diphenhydramine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.000987	0.0101	CcSEcCtD
Diphenhydramine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.000975	0.01	CcSEcCtD
Diphenhydramine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.000965	0.0099	CcSEcCtD
Diphenhydramine—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.000936	0.0096	CcSEcCtD
Diphenhydramine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000931	0.00955	CcSEcCtD
Diphenhydramine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.000919	0.00943	CcSEcCtD
Diphenhydramine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.000919	0.00943	CcSEcCtD
Diphenhydramine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000893	0.00916	CcSEcCtD
Diphenhydramine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000878	0.00901	CcSEcCtD
Diphenhydramine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.000868	0.00891	CcSEcCtD
Diphenhydramine—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.000838	0.0086	CcSEcCtD
Diphenhydramine—Neuritis—Prednisolone—chronic obstructive pulmonary disease	0.000837	0.00859	CcSEcCtD
Diphenhydramine—Irritability—Montelukast—chronic obstructive pulmonary disease	0.000783	0.00803	CcSEcCtD
Diphenhydramine—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.000755	0.00774	CcSEcCtD
Diphenhydramine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000733	0.00753	CcSEcCtD
Diphenhydramine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000714	0.00732	CcSEcCtD
Diphenhydramine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000705	0.00723	CcSEcCtD
Diphenhydramine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000699	0.00717	CcSEcCtD
Diphenhydramine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000693	0.00712	CcSEcCtD
Diphenhydramine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000668	0.00686	CcSEcCtD
Diphenhydramine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.000666	0.00683	CcSEcCtD
Diphenhydramine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00065	0.00667	CcSEcCtD
Diphenhydramine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000644	0.00661	CcSEcCtD
Diphenhydramine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000643	0.0066	CcSEcCtD
Diphenhydramine—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.000639	0.00656	CcSEcCtD
Diphenhydramine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000632	0.00649	CcSEcCtD
Diphenhydramine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000621	0.00637	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.00062	0.00636	CcSEcCtD
Diphenhydramine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.00625	CcSEcCtD
Diphenhydramine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000609	0.00625	CcSEcCtD
Diphenhydramine—Neuritis—Prednisone—chronic obstructive pulmonary disease	0.000608	0.00624	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000597	0.00613	CcSEcCtD
Diphenhydramine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000589	0.00604	CcSEcCtD
Diphenhydramine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000585	0.00601	CcSEcCtD
Diphenhydramine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000582	0.00597	CcSEcCtD
Diphenhydramine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000574	0.00589	CcSEcCtD
Diphenhydramine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000555	0.00569	CcSEcCtD
Diphenhydramine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000552	0.00567	CcSEcCtD
Diphenhydramine—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000537	0.00551	CcSEcCtD
Diphenhydramine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000536	0.0055	CcSEcCtD
Diphenhydramine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000528	0.00542	CcSEcCtD
Diphenhydramine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00052	0.00534	CcSEcCtD
Diphenhydramine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000516	0.00529	CcSEcCtD
Diphenhydramine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000515	0.00529	CcSEcCtD
Diphenhydramine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000511	0.00525	CcSEcCtD
Diphenhydramine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000511	0.00524	CcSEcCtD
Diphenhydramine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00051	0.00523	CcSEcCtD
Diphenhydramine—Levomethadyl Acetate—CHRNA3—chronic obstructive pulmonary disease	0.000509	0.105	CrCbGaD
Diphenhydramine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000508	0.00521	CcSEcCtD
Diphenhydramine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000505	0.00519	CcSEcCtD
Diphenhydramine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000498	0.00511	CcSEcCtD
Diphenhydramine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000495	0.00508	CcSEcCtD
Diphenhydramine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000495	0.00508	CcSEcCtD
Diphenhydramine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00504	CcSEcCtD
Diphenhydramine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00049	0.00503	CcSEcCtD
Diphenhydramine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00049	0.00503	CcSEcCtD
Diphenhydramine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000489	0.00502	CcSEcCtD
Diphenhydramine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000482	0.00494	CcSEcCtD
Diphenhydramine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000476	0.00488	CcSEcCtD
Diphenhydramine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000472	0.00485	CcSEcCtD
Diphenhydramine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000472	0.00485	CcSEcCtD
Diphenhydramine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00047	0.00482	CcSEcCtD
Diphenhydramine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000467	0.00479	CcSEcCtD
Diphenhydramine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000463	0.00476	CcSEcCtD
Diphenhydramine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000463	0.00476	CcSEcCtD
Diphenhydramine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000463	0.00475	CcSEcCtD
Diphenhydramine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000462	0.00475	CcSEcCtD
Diphenhydramine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000461	0.00473	CcSEcCtD
Diphenhydramine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000458	0.0047	CcSEcCtD
Diphenhydramine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000454	0.00466	CcSEcCtD
Diphenhydramine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000449	0.00461	CcSEcCtD
Diphenhydramine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000446	0.00458	CcSEcCtD
Diphenhydramine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000446	0.00457	CcSEcCtD
Diphenhydramine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000446	0.00457	CcSEcCtD
Diphenhydramine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00449	CcSEcCtD
Diphenhydramine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000436	0.00448	CcSEcCtD
Diphenhydramine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000436	0.00447	CcSEcCtD
Diphenhydramine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00043	0.00441	CcSEcCtD
Diphenhydramine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000428	0.00439	CcSEcCtD
Diphenhydramine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000428	0.00439	CcSEcCtD
Diphenhydramine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000421	0.00432	CcSEcCtD
Diphenhydramine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00431	CcSEcCtD
Diphenhydramine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00431	CcSEcCtD
Diphenhydramine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000405	0.00416	CcSEcCtD
Diphenhydramine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000402	0.00412	CcSEcCtD
Diphenhydramine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.00412	CcSEcCtD
Diphenhydramine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00407	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000395	0.00405	CcSEcCtD
Diphenhydramine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00039	0.004	CcSEcCtD
Diphenhydramine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00395	CcSEcCtD
Diphenhydramine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00395	CcSEcCtD
Diphenhydramine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000382	0.00392	CcSEcCtD
Diphenhydramine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.00389	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00386	CcSEcCtD
Diphenhydramine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00382	CcSEcCtD
Diphenhydramine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00382	CcSEcCtD
Diphenhydramine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.0038	CcSEcCtD
Diphenhydramine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00037	0.0038	CcSEcCtD
Diphenhydramine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00375	CcSEcCtD
Diphenhydramine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00375	CcSEcCtD
Diphenhydramine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000365	0.00374	CcSEcCtD
Diphenhydramine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00373	CcSEcCtD
Diphenhydramine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000362	0.00372	CcSEcCtD
Diphenhydramine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000362	0.00372	CcSEcCtD
Diphenhydramine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000362	0.00371	CcSEcCtD
Diphenhydramine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000358	0.00368	CcSEcCtD
Diphenhydramine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.00367	CcSEcCtD
Diphenhydramine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000355	0.00364	CcSEcCtD
Diphenhydramine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000355	0.00364	CcSEcCtD
Diphenhydramine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000355	0.00364	CcSEcCtD
Diphenhydramine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000352	0.00361	CcSEcCtD
Diphenhydramine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000352	0.00361	CcSEcCtD
Diphenhydramine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00361	CcSEcCtD
Diphenhydramine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00358	CcSEcCtD
Diphenhydramine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000348	0.00357	CcSEcCtD
Diphenhydramine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00355	CcSEcCtD
Diphenhydramine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000344	0.00353	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.00352	CcSEcCtD
Diphenhydramine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.00351	CcSEcCtD
Diphenhydramine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000341	0.0035	CcSEcCtD
Diphenhydramine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000341	0.0035	CcSEcCtD
Diphenhydramine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00348	CcSEcCtD
Diphenhydramine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00348	CcSEcCtD
Diphenhydramine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000339	0.00348	CcSEcCtD
Diphenhydramine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00347	CcSEcCtD
Diphenhydramine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000337	0.00346	CcSEcCtD
Diphenhydramine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.00344	CcSEcCtD
Diphenhydramine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.00341	CcSEcCtD
Diphenhydramine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00335	CcSEcCtD
Diphenhydramine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00335	CcSEcCtD
Diphenhydramine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000324	0.00333	CcSEcCtD
Diphenhydramine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000322	0.0033	CcSEcCtD
Diphenhydramine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000321	0.0033	CcSEcCtD
Diphenhydramine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000321	0.0033	CcSEcCtD
Diphenhydramine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00032	0.00329	CcSEcCtD
Diphenhydramine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00329	CcSEcCtD
Diphenhydramine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000319	0.00328	CcSEcCtD
Diphenhydramine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000315	0.00323	CcSEcCtD
Diphenhydramine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00317	CcSEcCtD
Diphenhydramine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000303	0.00311	CcSEcCtD
Diphenhydramine—Reboxetine—SLC6A4—chronic obstructive pulmonary disease	0.000298	0.0615	CrCbGaD
Diphenhydramine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.00303	CcSEcCtD
Diphenhydramine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000295	0.00303	CcSEcCtD
Diphenhydramine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000289	0.00297	CcSEcCtD
Diphenhydramine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00289	CcSEcCtD
Diphenhydramine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00289	CcSEcCtD
Diphenhydramine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00286	CcSEcCtD
Diphenhydramine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000277	0.00285	CcSEcCtD
Diphenhydramine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00283	CcSEcCtD
Diphenhydramine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00279	CcSEcCtD
Diphenhydramine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00279	CcSEcCtD
Diphenhydramine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000267	0.00274	CcSEcCtD
Diphenhydramine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00273	CcSEcCtD
Diphenhydramine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00269	CcSEcCtD
Diphenhydramine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00269	CcSEcCtD
Diphenhydramine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.00266	CcSEcCtD
Diphenhydramine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000259	0.00266	CcSEcCtD
Diphenhydramine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.00266	CcSEcCtD
Diphenhydramine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000259	0.00266	CcSEcCtD
Diphenhydramine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00265	CcSEcCtD
Diphenhydramine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00265	CcSEcCtD
Diphenhydramine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.00264	CcSEcCtD
Diphenhydramine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00264	CcSEcCtD
Diphenhydramine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00263	CcSEcCtD
Diphenhydramine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00261	CcSEcCtD
Diphenhydramine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00261	CcSEcCtD
Diphenhydramine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000253	0.00259	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00255	CcSEcCtD
Diphenhydramine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00254	CcSEcCtD
Diphenhydramine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000245	0.00252	CcSEcCtD
Diphenhydramine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00251	CcSEcCtD
Diphenhydramine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00251	CcSEcCtD
Diphenhydramine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.00251	CcSEcCtD
Diphenhydramine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000244	0.00251	CcSEcCtD
Diphenhydramine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.0025	CcSEcCtD
Diphenhydramine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00246	CcSEcCtD
Diphenhydramine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.00243	CcSEcCtD
Diphenhydramine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00237	CcSEcCtD
Diphenhydramine—Toremifene—CYP1A1—chronic obstructive pulmonary disease	0.000223	0.0461	CrCbGaD
Diphenhydramine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00223	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.00221	CcSEcCtD
Diphenhydramine—Toremifene—CYP1A2—chronic obstructive pulmonary disease	0.000215	0.0444	CrCbGaD
Diphenhydramine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.00207	CcSEcCtD
Diphenhydramine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00205	CcSEcCtD
Diphenhydramine—Clomifene—CYP1A1—chronic obstructive pulmonary disease	0.000193	0.0398	CrCbGaD
Diphenhydramine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00192	CcSEcCtD
Diphenhydramine—Cyclobenzaprine—CYP1A2—chronic obstructive pulmonary disease	0.000186	0.0384	CrCbGaD
Diphenhydramine—Clomifene—CYP1A2—chronic obstructive pulmonary disease	0.000186	0.0384	CrCbGaD
Diphenhydramine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00188	CcSEcCtD
Diphenhydramine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00187	CcSEcCtD
Diphenhydramine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00183	CcSEcCtD
Diphenhydramine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.00182	CcSEcCtD
Diphenhydramine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00176	CcSEcCtD
Diphenhydramine—Warfarin—CYP1A1—chronic obstructive pulmonary disease	0.000161	0.0332	CrCbGaD
Diphenhydramine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00162	CcSEcCtD
Diphenhydramine—Cyclobenzaprine—HTR2A—chronic obstructive pulmonary disease	0.000157	0.0324	CrCbGaD
Diphenhydramine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00161	CcSEcCtD
Diphenhydramine—Warfarin—CYP1A2—chronic obstructive pulmonary disease	0.000155	0.032	CrCbGaD
Diphenhydramine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00158	CcSEcCtD
Diphenhydramine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.00151	CcSEcCtD
Diphenhydramine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000146	0.0015	CcSEcCtD
Diphenhydramine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00149	CcSEcCtD
Diphenhydramine—Chlorphenamine—SLC6A4—chronic obstructive pulmonary disease	0.000143	0.0295	CrCbGaD
Diphenhydramine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00146	CcSEcCtD
Diphenhydramine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00144	CcSEcCtD
Diphenhydramine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.00144	CcSEcCtD
Diphenhydramine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.00144	CcSEcCtD
Diphenhydramine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00143	CcSEcCtD
Diphenhydramine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.00143	CcSEcCtD
Diphenhydramine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00142	CcSEcCtD
Diphenhydramine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00137	CcSEcCtD
Diphenhydramine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.00136	CcSEcCtD
Diphenhydramine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00132	CcSEcCtD
Diphenhydramine—Cinnarizine—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.0263	CrCbGaD
Diphenhydramine—Phenoxybenzamine—ADRB2—chronic obstructive pulmonary disease	0.000127	0.0263	CrCbGaD
Diphenhydramine—Modafinil—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.0262	CrCbGaD
Diphenhydramine—Cinnarizine—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.0254	CrCbGaD
Diphenhydramine—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	0.00012	0.0248	CrCbGaD
Diphenhydramine—Fenoprofen—ALB—chronic obstructive pulmonary disease	0.000117	0.0242	CrCbGaD
Diphenhydramine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00119	CcSEcCtD
Diphenhydramine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00114	CcSEcCtD
Diphenhydramine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000107	0.0011	CcSEcCtD
Diphenhydramine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00106	CcSEcCtD
Diphenhydramine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00105	CcSEcCtD
Diphenhydramine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00105	CcSEcCtD
Diphenhydramine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00104	CcSEcCtD
Diphenhydramine—Phenprocoumon—ALB—chronic obstructive pulmonary disease	0.000101	0.0208	CrCbGaD
Diphenhydramine—Trimipramine—SLC6A4—chronic obstructive pulmonary disease	9.87e-05	0.0204	CrCbGaD
Diphenhydramine—Nausea—Prednisone—chronic obstructive pulmonary disease	9.62e-05	0.000987	CcSEcCtD
Diphenhydramine—Doxepin—SLC6A4—chronic obstructive pulmonary disease	9.4e-05	0.0194	CrCbGaD
Diphenhydramine—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	9.22e-05	0.019	CrCbGaD
Diphenhydramine—Warfarin—ALB—chronic obstructive pulmonary disease	8.95e-05	0.0185	CrCbGaD
Diphenhydramine—Tamoxifen—CYP1A1—chronic obstructive pulmonary disease	8.91e-05	0.0184	CrCbGaD
Diphenhydramine—Tamoxifen—CYP1A2—chronic obstructive pulmonary disease	8.59e-05	0.0177	CrCbGaD
Diphenhydramine—Doxepin—CYP1A2—chronic obstructive pulmonary disease	8.56e-05	0.0177	CrCbGaD
Diphenhydramine—Methadone—CYP1A2—chronic obstructive pulmonary disease	8.52e-05	0.0176	CrCbGaD
Diphenhydramine—Promazine—CYP1A2—chronic obstructive pulmonary disease	7.61e-05	0.0157	CrCbGaD
Diphenhydramine—Trimipramine—HTR2A—chronic obstructive pulmonary disease	7.58e-05	0.0157	CrCbGaD
Diphenhydramine—Imipramine—SLC6A4—chronic obstructive pulmonary disease	7.32e-05	0.0151	CrCbGaD
Diphenhydramine—Promethazine—HTR2A—chronic obstructive pulmonary disease	7.3e-05	0.0151	CrCbGaD
Diphenhydramine—Amitriptyline—SLC6A4—chronic obstructive pulmonary disease	7.27e-05	0.015	CrCbGaD
Diphenhydramine—Doxepin—HTR2A—chronic obstructive pulmonary disease	7.23e-05	0.0149	CrCbGaD
Diphenhydramine—Imipramine—CYP1A2—chronic obstructive pulmonary disease	6.66e-05	0.0138	CrCbGaD
Diphenhydramine—Amitriptyline—CYP1A2—chronic obstructive pulmonary disease	6.62e-05	0.0137	CrCbGaD
Diphenhydramine—Phenytoin—ALB—chronic obstructive pulmonary disease	6.5e-05	0.0134	CrCbGaD
Diphenhydramine—Promazine—HTR2A—chronic obstructive pulmonary disease	6.42e-05	0.0133	CrCbGaD
Diphenhydramine—Imipramine—HTR2A—chronic obstructive pulmonary disease	5.62e-05	0.0116	CrCbGaD
Diphenhydramine—Amitriptyline—HTR2A—chronic obstructive pulmonary disease	5.59e-05	0.0115	CrCbGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.08e-05	0.000885	CbGpPWpGaD
Diphenhydramine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.05e-05	0.000879	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.03e-05	0.000874	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.99e-05	0.000867	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.95e-05	0.000856	CbGpPWpGaD
Diphenhydramine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.93e-05	0.000853	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.9e-05	0.000846	CbGpPWpGaD
Diphenhydramine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.89e-05	0.000845	CbGpPWpGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.89e-05	0.000844	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.88e-05	0.000843	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.87e-05	0.000841	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.85e-05	0.000837	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	3.85e-05	0.000835	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.84e-05	0.000834	CbGpPWpGaD
Diphenhydramine—Amitriptyline—ALB—chronic obstructive pulmonary disease	3.82e-05	0.0079	CrCbGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.82e-05	0.000829	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.82e-05	0.000829	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	3.75e-05	0.000814	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.74e-05	0.000812	CbGpPWpGaD
Diphenhydramine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.72e-05	0.000808	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.71e-05	0.000806	CbGpPWpGaD
Diphenhydramine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.69e-05	0.000801	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	3.69e-05	0.000801	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.67e-05	0.000797	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.67e-05	0.000797	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.64e-05	0.00079	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	3.64e-05	0.00079	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.64e-05	0.00079	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.64e-05	0.00079	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.62e-05	0.000787	CbGpPWpGaD
Diphenhydramine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.62e-05	0.000786	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.59e-05	0.00078	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.58e-05	0.000778	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.57e-05	0.000775	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.57e-05	0.000774	CbGpPWpGaD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.53e-05	0.000767	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.53e-05	0.000766	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.53e-05	0.000765	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	3.49e-05	0.000759	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.49e-05	0.000757	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.47e-05	0.000754	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.38e-05	0.000735	CbGpPWpGaD
Diphenhydramine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.33e-05	0.000722	CbGpPWpGaD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.29e-05	0.000715	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.28e-05	0.000712	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.26e-05	0.000707	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.25e-05	0.000705	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.18e-05	0.00069	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.15e-05	0.000685	CbGpPWpGaD
Diphenhydramine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.15e-05	0.000685	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.13e-05	0.000679	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.12e-05	0.000678	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.11e-05	0.000675	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.1e-05	0.000674	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.09e-05	0.00067	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GCLC—chronic obstructive pulmonary disease	3.05e-05	0.000662	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3e-05	0.00065	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.99e-05	0.000649	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.97e-05	0.000645	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	2.92e-05	0.000633	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.89e-05	0.000627	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.86e-05	0.00062	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.85e-05	0.000619	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.84e-05	0.000617	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.79e-05	0.000606	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.79e-05	0.000605	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—CTGF—chronic obstructive pulmonary disease	2.78e-05	0.000604	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.78e-05	0.000603	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.77e-05	0.000601	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.76e-05	0.000599	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.75e-05	0.000597	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.72e-05	0.000589	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.7e-05	0.000585	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.68e-05	0.000581	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.58e-05	0.00056	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.56e-05	0.000557	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.54e-05	0.000551	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.32e-05	0.000504	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.24e-05	0.000486	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.21e-05	0.00048	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.2e-05	0.000478	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.16e-05	0.000469	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.16e-05	0.000468	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.14e-05	0.000464	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.14e-05	0.000464	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.12e-05	0.00046	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.12e-05	0.000459	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.11e-05	0.000458	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.1e-05	0.000456	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.08e-05	0.000452	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.05e-05	0.000445	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.02e-05	0.00044	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2e-05	0.000433	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.99e-05	0.000432	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.98e-05	0.000431	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.97e-05	0.000427	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.97e-05	0.000427	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.97e-05	0.000427	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.96e-05	0.000426	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.95e-05	0.000424	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.95e-05	0.000423	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.93e-05	0.000419	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.91e-05	0.000415	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.91e-05	0.000414	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.89e-05	0.00041	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.86e-05	0.000404	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.85e-05	0.000401	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.83e-05	0.000398	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.81e-05	0.000393	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.000393	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.8e-05	0.00039	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.79e-05	0.00039	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.79e-05	0.000389	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.78e-05	0.000387	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.78e-05	0.000387	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.78e-05	0.000386	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.75e-05	0.000381	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.72e-05	0.000374	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.71e-05	0.00037	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.71e-05	0.00037	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.7e-05	0.00037	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.7e-05	0.000369	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.68e-05	0.000365	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.68e-05	0.000364	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.68e-05	0.000364	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.67e-05	0.000363	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.65e-05	0.000359	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.64e-05	0.000355	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.62e-05	0.000351	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.59e-05	0.000346	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.59e-05	0.000344	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.56e-05	0.000339	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.55e-05	0.000337	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.53e-05	0.000333	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.52e-05	0.00033	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.52e-05	0.000329	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.5e-05	0.000326	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.42e-05	0.000308	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.42e-05	0.000308	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.42e-05	0.000307	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.4e-05	0.000304	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.39e-05	0.000303	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.38e-05	0.000299	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.37e-05	0.000297	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.36e-05	0.000295	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.32e-05	0.000287	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.31e-05	0.000283	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.3e-05	0.000283	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.27e-05	0.000275	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	1.27e-05	0.000275	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.26e-05	0.000274	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.25e-05	0.000271	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.000268	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.23e-05	0.000266	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.22e-05	0.000264	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	1.21e-05	0.000263	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000263	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.000261	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.16e-05	0.000252	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.00025	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.15e-05	0.000249	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.14e-05	0.000248	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.13e-05	0.000246	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.07e-05	0.000232	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000229	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000229	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.05e-05	0.000229	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.05e-05	0.000228	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000227	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000226	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.04e-05	0.000225	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.03e-05	0.000224	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.03e-05	0.000224	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.66e-06	0.00021	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.64e-06	0.000209	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.64e-06	0.000209	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.56e-06	0.000208	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.53e-06	0.000207	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.51e-06	0.000206	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.48e-06	0.000206	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	9.43e-06	0.000205	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.41e-06	0.000204	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.16e-06	0.000199	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.93e-06	0.000194	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.83e-06	0.000192	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.76e-06	0.00019	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.75e-06	0.00019	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.69e-06	0.000189	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.69e-06	0.000189	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.61e-06	0.000187	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.55e-06	0.000186	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	8.41e-06	0.000183	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.37e-06	0.000182	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.23e-06	0.000179	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.23e-06	0.000179	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	8.16e-06	0.000177	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.06e-06	0.000175	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	8.04e-06	0.000175	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.95e-06	0.000173	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.84e-06	0.00017	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	7.84e-06	0.00017	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.81e-06	0.000169	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.78e-06	0.000169	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.65e-06	0.000166	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.5e-06	0.000163	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.31e-06	0.000159	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.3e-06	0.000159	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.25e-06	0.000157	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.21e-06	0.000156	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.15e-06	0.000155	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.92e-06	0.00015	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.72e-06	0.000146	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.66e-06	0.000145	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.4e-06	0.000139	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.37e-06	0.000138	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.31e-06	0.000137	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.29e-06	0.000137	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	6.23e-06	0.000135	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.19e-06	0.000134	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.11e-06	0.000133	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.1e-06	0.000132	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.01e-06	0.00013	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.96e-06	0.000129	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.83e-06	0.000126	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.73e-06	0.000124	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.69e-06	0.000124	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.39e-06	0.000117	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.17e-06	0.000112	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.09e-06	0.00011	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.92e-06	0.000107	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.84e-06	0.000105	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.71e-06	0.000102	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.68e-06	0.000101	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.6e-06	9.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.5e-06	9.77e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.33e-06	9.4e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.29e-06	9.31e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.2e-06	9.11e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.14e-06	8.99e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.13e-06	8.97e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.1e-06	8.91e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.85e-06	8.36e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.79e-06	8.23e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.78e-06	8.2e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.72e-06	8.07e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.67e-06	7.96e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.51e-06	7.61e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.17e-06	6.89e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.12e-06	6.78e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.9e-06	6.3e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.86e-06	6.2e-05	CbGpPWpGaD
